Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B. Gilbert, Lynn Morris, Amanda Eaton et al.|Nature Medicine|2022Cited by 132
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E. Seaton, Georgia D. Tomaras, Yunda Huang et al.|EBioMedicine|2023Cited by 33
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, James I. Mullins, Hongjun Bai et al.|Proceedings of the National Academy of Sciences|2024Cited by 22
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Paul T. Edlefsen, Elena E. Giorgi et al.|mBio|2025Cited by 3
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infectionJames I. Mullins, Carolyn Williamson, Wenjie Deng et al.|Nature Communications|2026Cited by 3